BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25785718)

  • 1. A novel class of mitochondria-targeted soft electrophiles modifies mitochondrial proteins and inhibits mitochondrial metabolism in breast cancer cells through redox mechanisms.
    Vayalil PK; Oh JY; Zhou F; Diers AR; Smith MR; Golzarian H; Oliver PG; Smith RA; Murphy MP; Velu SE; Landar A
    PLoS One; 2015; 10(3):e0120460. PubMed ID: 25785718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels.
    Smith MR; Vayalil PK; Zhou F; Benavides GA; Beggs RR; Golzarian H; Nijampatnam B; Oliver PG; Smith RA; Murphy MP; Velu SE; Landar A
    Redox Biol; 2016 Aug; 8():136-48. PubMed ID: 26774751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
    Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
    Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
    Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.
    Cheng G; Zielonka J; McAllister DM; Mackinnon AC; Joseph J; Dwinell MB; Kalyanaraman B
    BMC Cancer; 2013 Jun; 13():285. PubMed ID: 23764021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity.
    Pokrzywinski KL; Biel TG; Kryndushkin D; Rao VA
    PLoS One; 2016; 11(12):e0168283. PubMed ID: 28030582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
    Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
    Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.
    Sohn YS; Tamir S; Song L; Michaeli D; Matouk I; Conlan AR; Harir Y; Holt SH; Shulaev V; Paddock ML; Hochberg A; Cabanchick IZ; Onuchic JN; Jennings PA; Nechushtai R; Mittler R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14676-81. PubMed ID: 23959881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
    Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
    Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
    Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-targeted platinum(ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin.
    Li J; He X; Zou Y; Chen D; Yang L; Rao J; Chen H; Chan MCW; Li L; Guo Z; Zhang LW; Chen C
    Metallomics; 2017 Jun; 9(6):726-733. PubMed ID: 28513634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of mitochondrial targets of arginase in human breast cancer.
    Singh R; Avliyakulov NK; Braga M; Haykinson MJ; Martinez L; Singh V; Parveen M; Chaudhuri G; Pervin S
    PLoS One; 2013; 8(11):e79242. PubMed ID: 24223914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Mitochondrial Dysfunction Induced by TPP
    Fuentes-Retamal S; Sandoval-Acuña C; Peredo-Silva L; Guzmán-Rivera D; Pavani M; Torrealba N; Truksa J; Castro-Castillo V; Catalán M; Kemmerling U; Urra FA; Ferreira J
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer.
    Chang JC; Chang HS; Wu YC; Cheng WL; Lin TT; Chang HJ; Kuo SJ; Chen ST; Liu CS
    J Exp Clin Cancer Res; 2019 Jan; 38(1):30. PubMed ID: 30674338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria.
    Modica-Napolitano JS; Bharath LP; Hanlon AJ; Hurley LD
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.